NO982172L - Anvendelse av epinastin for behandling av smerter - Google Patents

Anvendelse av epinastin for behandling av smerter

Info

Publication number
NO982172L
NO982172L NO982172A NO982172A NO982172L NO 982172 L NO982172 L NO 982172L NO 982172 A NO982172 A NO 982172A NO 982172 A NO982172 A NO 982172A NO 982172 L NO982172 L NO 982172L
Authority
NO
Norway
Prior art keywords
pain
epinastine
treatment
bing
neuralgia
Prior art date
Application number
NO982172A
Other languages
English (en)
Other versions
NO982172D0 (no
Inventor
Birgit Jung
Christopher John Montagu Meade
Michel Pairet
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO982172L publication Critical patent/NO982172L/no
Publication of NO982172D0 publication Critical patent/NO982172D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Den foreliggende oppfinnelse vedrører anvendelse av Epinastin som legemiddel for behandling av smerter, særlig av migrene, Bing-Horton syndrom, spenningshodesmerter, muskelsmerter, betennelsessmerter eller neuralgier.
NO982172A 1995-11-14 1998-05-13 Anvendelse av epinastin for behandling av smerter NO982172D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19542281A DE19542281C2 (de) 1995-11-14 1995-11-14 Verwendung von Epinastin für die Behandlung der Migräne
PCT/EP1996/004957 WO1997017971A1 (de) 1995-11-14 1996-11-13 Verwendung von epinastin für die behandlung von schmerzen

Publications (2)

Publication Number Publication Date
NO982172L true NO982172L (no) 1998-05-13
NO982172D0 NO982172D0 (no) 1998-05-13

Family

ID=7777343

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982172A NO982172D0 (no) 1995-11-14 1998-05-13 Anvendelse av epinastin for behandling av smerter

Country Status (32)

Country Link
US (1) US5942503A (no)
EP (1) EP0861081B1 (no)
JP (2) JP4264850B2 (no)
KR (1) KR100435611B1 (no)
CN (1) CN1104242C (no)
AR (1) AR004321A1 (no)
AT (1) ATE213160T1 (no)
AU (1) AU706112B2 (no)
BG (1) BG62511B1 (no)
BR (1) BR9611502A (no)
CA (1) CA2232008C (no)
CO (1) CO4770978A1 (no)
CZ (1) CZ290115B6 (no)
DE (2) DE19542281C2 (no)
DK (1) DK0861081T3 (no)
EE (1) EE03512B1 (no)
ES (1) ES2171746T3 (no)
HK (1) HK1015280A1 (no)
HU (1) HU225759B1 (no)
IL (1) IL123601A (no)
NO (1) NO982172D0 (no)
NZ (1) NZ322467A (no)
PL (1) PL186615B1 (no)
PT (1) PT861081E (no)
RO (1) RO118373B1 (no)
RU (2) RU2217144C2 (no)
SK (1) SK61398A3 (no)
TR (1) TR199800853T2 (no)
TW (1) TW575423B (no)
UY (1) UY24354A1 (no)
WO (1) WO1997017971A1 (no)
ZA (1) ZA969520B (no)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586458B1 (en) 1996-08-16 2003-07-01 Pozen Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
ES2234324T3 (es) * 1998-11-02 2005-06-16 MERCK & CO., INC. Combinaciones de un agonista 5ht1b/1d y un inhibidor selectivo de cox-2 para el tratamiento de la migraña.
AU3596500A (en) * 1999-02-19 2000-09-04 Pozen, Inc. Formulation of 5-ht agonists with cox-2 inhibitors
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
JP2002087963A (ja) * 2000-09-08 2002-03-27 Nippon Boehringer Ingelheim Co Ltd 直接打錠により製造されたエピナスチン含有錠剤
DE10152973A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Int Neue trockene und wässrige Epinastin-Sirup-Formulierung
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
AU2003250073A1 (en) * 2002-08-02 2004-02-25 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
SI1575566T1 (sl) 2002-12-26 2012-08-31 Pozen Inc Veäśplastna dozirna oblika vsebujoäśa naproksen in triptane
EP1452177A1 (en) * 2003-02-27 2004-09-01 Boehringer Ingelheim International GmbH Pharmaceutical formulations comprising sodium laurylsulfate as bitterness masking agent
KR20080034916A (ko) * 2005-07-08 2008-04-22 센주 세이야꾸 가부시키가이샤 에피나스틴을 포함하는 경피 흡수 안과 제제
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
WO2007110380A1 (en) * 2006-03-25 2007-10-04 Boehringer Ingelheim International Gmbh Insect bite relief preparation comprising epinastine
US8536445B2 (en) * 2006-06-02 2013-09-17 Emcore Solar Power, Inc. Inverted metamorphic multijunction solar cells
EP1875899A1 (en) * 2006-06-29 2008-01-09 Laboratorios Del Dr. Esteve, S.A. Use of 5HT7 receptor agonists for the treatment of pain
US20080102097A1 (en) * 2006-10-31 2008-05-01 Zanella John M Device and method for treating osteolysis using a drug depot to deliver an anti-inflammatory agent
US8470360B2 (en) * 2008-04-18 2013-06-25 Warsaw Orthopedic, Inc. Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
RU2464984C2 (ru) * 2007-11-22 2012-10-27 Общество с ограниченной ответственностью "МС-Вита" Нестероидное противовоспалительное лекарственное средство
US8629172B2 (en) 2008-04-18 2014-01-14 Warsaw Orthopedic, Inc. Methods and compositions for treating post-operative pain comprising clonidine
US20090264477A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc., An Indiana Corporation Beta adrenergic receptor agonists for treatment of pain and/or inflammation
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
US9072727B2 (en) * 2008-04-18 2015-07-07 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of degenerative disc disease
US9132119B2 (en) * 2008-04-18 2015-09-15 Medtronic, Inc. Clonidine formulation in a polyorthoester carrier
US8420114B2 (en) * 2008-04-18 2013-04-16 Warsaw Orthopedic, Inc. Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
US20090263451A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US9132085B2 (en) 2008-04-18 2015-09-15 Warsaw Orthopedic, Inc. Compositions and methods for treating post-operative pain using clonidine and bupivacaine
US8956641B2 (en) * 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of inflammatory diseases
US8883768B2 (en) * 2008-04-18 2014-11-11 Warsaw Orthopedic, Inc. Fluocinolone implants to protect against undesirable bone and cartilage destruction
US20090264489A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation
US9610243B2 (en) 2008-04-18 2017-04-04 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US8557273B2 (en) 2008-04-18 2013-10-15 Medtronic, Inc. Medical devices and methods including polymers having biologically active agents therein
US20090263489A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
US8722079B2 (en) * 2008-04-18 2014-05-13 Warsaw Orthopedic, Inc. Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
US8946277B2 (en) 2008-04-18 2015-02-03 Warsaw Orthopedic, Inc. Clonidine formulations in a biodegradable polymer carrier
US20100098746A1 (en) * 2008-10-20 2010-04-22 Warsaw Orthopedic, Inc. Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
US8822546B2 (en) * 2008-12-01 2014-09-02 Medtronic, Inc. Flowable pharmaceutical depot
US20100228097A1 (en) * 2009-03-04 2010-09-09 Warsaw Orthopedic, Inc. Methods and compositions to diagnose pain
US20100239632A1 (en) * 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
US8617583B2 (en) * 2009-07-17 2013-12-31 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis
US8231891B2 (en) * 2009-07-31 2012-07-31 Warsaw Orthopedic, Inc. Implantable drug depot for weight control
US20110097375A1 (en) 2009-10-26 2011-04-28 Warsaw Orthopedic, Inc. Formulation for preventing or reducing bleeding at a surgical site
DK3041506T3 (da) 2013-09-02 2023-02-27 Univ Melbourne Behandlingsfremgangsmåde
CN105708840A (zh) * 2014-12-01 2016-06-29 重庆安格龙翔医药科技有限公司 一种盐酸依匹斯汀组合物
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
KR102041389B1 (ko) 2017-12-12 2019-11-27 (주)프론트바이오 N-(9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일)-2-하이드록시벤즈아미드 및 2-((9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일) 카바모일)페닐 아세테이트의 화합물, 이의 제조방법 및 이를 포함하는 항염증 및 진통제 조성물
KR20220008824A (ko) 2019-04-17 2022-01-21 컴퍼스 패쓰파인더 리미티드 실로시빈으로 불안 장애, 두통 장애 및 섭식 장애를 치료하는 방법
JP6963651B2 (ja) * 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung

Also Published As

Publication number Publication date
UY24354A1 (es) 2001-10-25
BG102408A (en) 1998-12-30
RU2238733C2 (ru) 2004-10-27
DK0861081T3 (da) 2002-05-27
ZA969520B (en) 1997-05-14
EP0861081B1 (de) 2002-02-13
CA2232008A1 (en) 1997-05-22
PL326653A1 (en) 1998-10-12
ES2171746T3 (es) 2002-09-16
DE59608738D1 (de) 2002-03-21
AU7623096A (en) 1997-06-05
JP2000500446A (ja) 2000-01-18
PL186615B1 (pl) 2004-02-27
DE19542281A1 (de) 1997-05-15
HUP9903489A3 (en) 2001-12-28
EP0861081A1 (de) 1998-09-02
CO4770978A1 (es) 1999-04-30
ATE213160T1 (de) 2002-02-15
CZ290115B6 (cs) 2002-06-12
CA2232008C (en) 2004-01-06
PT861081E (pt) 2002-06-28
BG62511B1 (bg) 2000-01-31
NZ322467A (en) 2000-01-28
RU2217144C2 (ru) 2003-11-27
IL123601A0 (en) 1998-10-30
EE9800158A (et) 1998-12-15
IL123601A (en) 2002-12-01
HK1015280A1 (en) 1999-10-15
TW575423B (en) 2004-02-11
CN1202111A (zh) 1998-12-16
AU706112B2 (en) 1999-06-10
RO118373B1 (ro) 2003-05-30
AR004321A1 (es) 1998-11-04
KR19990067527A (ko) 1999-08-25
HUP9903489A2 (hu) 2000-03-28
NO982172D0 (no) 1998-05-13
CN1104242C (zh) 2003-04-02
HU225759B1 (en) 2007-08-28
MX9803206A (es) 1998-09-30
JP4264850B2 (ja) 2009-05-20
TR199800853T2 (xx) 1998-09-21
US5942503A (en) 1999-08-24
JP4850880B2 (ja) 2012-01-11
SK61398A3 (en) 1998-09-09
BR9611502A (pt) 1999-03-02
WO1997017971A1 (de) 1997-05-22
JP2009019050A (ja) 2009-01-29
CZ149898A3 (cs) 1998-10-14
KR100435611B1 (ko) 2005-01-13
DE19542281C2 (de) 1997-12-04
EE03512B1 (et) 2001-10-15

Similar Documents

Publication Publication Date Title
NO982172L (no) Anvendelse av epinastin for behandling av smerter
NO992400L (no) Nye substituerte pyrazolderivater
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
NO991732L (no) Nye heterocyklylmetylsubstituerte pyrazolderivater
ATE462424T1 (de) Therapeutische anwendung von zerstäubtem s- nitrosoglutathion bei zystischer fibrose
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
DE69829112D1 (de) Butyrate derivaten zur behandlung von fibromyalgia und chronische müdigkeit-syndrom
ES2166110T3 (es) Agonistas no alostericos de gabaa para tratar trastornos del sueño.
NO20003233L (no) 4-hydroksykinolin-3-karboksamider og hydrazider som antivirale midler
NO20060242L (no) Kombinasjonen av en serotonin-reopptaksinhibitor og agomelatin
DK1143967T3 (da) Anticonvulsive derivater egnede til behandling af Hortons hovedpine
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
DE69738613D1 (de) Prävention und behandlung von skeletterkrankungen mit ep2 subtyp selektiven prostaglandin e2 agonisten
ATE315390T1 (de) Zyklische polyamine zur behandlung der thrombozytopenie
BR0307951A (pt) Co-terapia para o tratamento de enxaqueca compreendendo derivados de anticonvulsivantes e agentes antienxaqueca
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
NO984760L (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
NO20005981L (no) Anvendelse av 2-hydroksy-4-trifluorbenzosyrederivater som inhibitorer av aktivering av den nukleære transkripsjonsfaktor NF- <kappa>B
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
NO20012423L (no) Antikonvulsjonsmiddelderivater som er nyttige ved behandling av posttraumatiske stresslidelser
HUP0300958A2 (en) Vasoregulation device
ES2153584T3 (es) Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos.
EA199800819A1 (ru) Способ лечения биполярного расстройства
BR9606955A (pt) Heterocicloalquenos substituísos
DK0831722T3 (da) Gelsystem, som omfatter carrageenan og kokosnødendosperm

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application